NEWS

WIRES

OTHER

Sancilio & Company, Inc. Announces Expanded Contract Manufacturing Facility, Specializing in Tablet, Capsules, Packaging and Labeling Services

Sancilio & Company, Inc. announces the opening of their new expanded 2000 sq. ft. contract manufacturing facility. The GMP facility specializes in small batch manufacturing of tablets and capsules as well as packaging and labeling services.

Strategically positioned adjacent to Sancilio & Company's Pharmaceutical Laboratory, the state-of the-art, climate-controlled facility enables pharmaceutical, biotechnology and nutraceutical clients access to their full range of analytical services which include Formulation Development, Quality Control, Quality Assurance and Regulatory Affairs.

According to Fred D. Sancilio, Ph.D., CEO and Chief Scientist of Sancilio & Company, Inc., "The new, fully cGMP compliant combined operation is FDA registered, and licensed for DEA Schedule 2, 3 and 4. The key attributes of both the manufacturing facility and the laboratory are rapid turnaround and competitive pricing."

Nealie Newberger, Ph.D., Vice President of Laboratory Services of Sancilio & Company, Inc., said, " We anticipate that the addition of Small Batch Contract Manufacturing to our roster of services strategically positions the company as a full-service pharmaceutical and nutritional enterprise."

About Sancilio & Company, Inc. (SCI)

Dr. Frederick Sancilio founded SCI in 2006. The focus of SCI is to provide pharmaceutical and nutritional companies access to high quality but low cost alternatives to major providers of machinery, products and services.

Leveraging over 30 years of experience, SCI has established relationships with all the major pharmaceutical companies and regulatory agencies to speed up the drug approval process by providing insightful methods of getting things done in a cost effective manner. SCI can provide expert advice to get products on the market cost effectively. We can also provide the machinery needed to expedite the process in a timely fashion.

SCI maintains corporate and scientific operations at 3874 Fiscal Court, Suite 200, Riviera Beach, Florida. Additional locations: Pudong District, Shanghai, PRC and Montville, N.J., USA. For more information on services available visit www.sanciliopharmaceuticallabs.com